{"entity":{"id":"valius-sciences","kind":"company","name":"Valius Sciences","aka":[],"tldr":"Valius Sciences offers exhaustive tumour profiling for rare and advanced cancers, what it calls maximalist diagnostics for the toughest cases, and has raised 13 million dollars to build it.","summary":"Valius Sciences runs exhaustive molecular and functional profiling of a patient's tumour to find therapeutic targets and treatment options in rare and advanced cancers, working with the patient's physicians; its team includes the physicians Bicky Thapa and Katherine Fuh. The company announced a 13 million dollar raise to transform cancer diagnostics, and Sid Sijbrandij, the GitLab co-founder whose osteosarcoma led to the Even One Ventures portfolio, describes using it. It also appears on the Sijbrandij Foundation's Future of Cancer Care Today list.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.valiussciences.com/"},{"label":"Even One Ventures portfolio","url":"https://evenone.ventures/"}],"tags":["startup","evenone-portfolio","oncology"],"related":[],"cancers":[],"sections":[],"technologies":["cgp","functional-drug-testing"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"United States (head office not published)","country":"US","companyType":"diagnostics","website":"https://www.valiussciences.com/","stage":"startup","investors":["evenone-ventures"],"funding":[]},"route":"/companies/valius-sciences/","neighbours":{"technology":[{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"},{"id":"functional-drug-testing","kind":"technology","name":"Functional (ex vivo) drug testing","route":"/technologies/functional-drug-testing/"}],"company":[{"id":"evenone-ventures","kind":"company","name":"Even One Ventures","route":"/companies/evenone-ventures/"}]}}